SeLux Diagnostics

About:

SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.

Website: http://www.seluxdx.com

Twitter/X: SeluxDX

Top Investors: RA Capital Management, Sands Capital Ventures, National Institutes of Health, Northpond Ventures, Biomedical Advanced Research and Development Authority (BARDA)

Description:

SeLux Diagnostics is a developer of the next-generation phenotyping platform that provides personalized antimicrobial therapies to patients. The company is revolutionizing patient care by expediting the selection of personalized antimicrobial therapy for all infectious disease patients. This advancement will save lives, reduce hospital stays, and address the escalating antibiotic resistance epidemic by minimizing the overuse of broad-spectrum agents.